- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 5, 2025 | 72.16M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 71.76M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 71.57M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 41.65M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 41.65M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $212K |
| Capex | Q3 2025 · Sep 30, 2024 | $302K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $4.58M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$35.65M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $0 |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $77.71M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $46.3M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $275.98M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $597.93M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $668.68M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $1.06B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $1.57B |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $134.17M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$92.47M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$74.39M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$54.34M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $143.26M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $535.26M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $389.49M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $694.63M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $161.85M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $455.62M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $987.42M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $2.27B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.07 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$13.96 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.42 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$1.85 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.07 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$13.96 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.42 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$1.85 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $21.04M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $64.24M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $18.37M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $53.94M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $2.89M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $8.28M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $2.57M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $8.5M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$76.78M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$998.83M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$398.66M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$523.39M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$17.43M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$77.14M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$40.2M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$19.51M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$107.85M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$1.01B |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$14.38M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$71.25M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $74.94M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $203.44M |
| Gross Profit restated | Q3 2025 · Sep 30, 2024 | $39.06M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $110.02M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $47.35M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $142.67M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $23.81M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $74.48M |
| Revenue | Q3 2025 · Sep 30, 2025 | $122.29M |
| Revenue | Q3 2025 · Sep 30, 2025 | $346.12M |
| Revenue | Q3 2025 · Sep 30, 2024 | $62.87M |
| Revenue | Q3 2025 · Sep 30, 2024 | $184.5M |